Literature DB >> 34181160

Update on Pulmonary Cryptococcosis.

Deborah Yamamura1,2, Jianping Xu3.   

Abstract

Pulmonary cryptococcosis is a common but underdiagnosed opportunistic fungal infection in both immunocompromised and immunocompetent patients. The causal agents include at least eight evolutionary distinct haploid lineages as well as their hybrids of the human pathogenic Cryptococcus complex. In this update, we review recent advances in epidemiology, mode of transmission, risk factors, diagnostic methods, and therapy of pulmonary cryptococcosis. Our review suggests significant challenges and opportunities for research, from bedside to benchside and back to bedside.

Entities:  

Keywords:  Cryptococcal genotypes; Diagnosis; Pulmonary infections; Treatment

Year:  2021        PMID: 34181160     DOI: 10.1007/s11046-021-00575-9

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  57 in total

Review 1.  Searching for clues for eighteen years: Deciphering the ecological determinants of Cryptococcus gattii on Vancouver Island, British Columbia.

Authors:  Emily Sohanna Acheson; Eleni Galanis; Karen Bartlett; Sunny Mak; Brian Klinkenberg
Journal:  Med Mycol       Date:  2018-02-01       Impact factor: 4.076

2.  Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013.

Authors:  Chien-Yuan Chen; Wang-Huei Sheng; Feng-Ming Tien; Po-Chu Lee; Shang-Yi Huang; Jih-Luh Tang; Woei Tsay; Hwei-Fang Tien; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2018-01-31       Impact factor: 4.399

Review 3.  A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.

Authors:  Felix Bongomin; Rita O Oladele; Sara Gago; Caroline B Moore; Malcolm D Richardson
Journal:  Mycoses       Date:  2018-02-14       Impact factor: 4.377

4.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

Review 5.  Epidemiology of Cryptococcus and cryptococcosis in Western Africa.

Authors:  Chidinma Lynda Akaihe; Emeka Innocent Nweze
Journal:  Mycoses       Date:  2020-10-08       Impact factor: 4.377

6.  Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients.

Authors:  Wei-Chou Chang; Ching Tzao; Hsian-He Hsu; Shih-Chun Lee; Kun-Lun Huang; Ho-Jui Tung; Cheng-Yu Chen
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

7.  Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: A case study.

Authors:  Min Chen; Nan Hong; Shan Hu; Peng Wang; HongZhi Guan; Meng Xiao; Xinlin Zhu; Abdullah M S Al-Hatmi; Zhe Zhou; Lei Gao; Teun Boekhout; Jianping Xu; Yingchun Xu; Wanqing Liao; Ying Yang
Journal:  J Infect       Date:  2020-06-23       Impact factor: 6.072

8.  Cryptococcus gattii infection in an immunocompetent host in Greece.

Authors:  Marina Andreou; Massimo Cogliati; Fevronia Kolonitsiou; Charalampos Stroumpos; Vasiliki Stamouli; Panagiota Ravazoula; Dimitrios Siagris; Helen Papadogeorgaki; Myrto Christofidou; Alexandra Lekkou
Journal:  Med Mycol Case Rep       Date:  2019-12-03

Review 9.  The cause and effect of Cryptococcus interactions with the host.

Authors:  Elizabeth R Ballou; Simon A Johnston
Journal:  Curr Opin Microbiol       Date:  2017-11-15       Impact factor: 7.934

View more
  1 in total

1.  Respiratory Mycoses: A Call to Action to Recognize, Educate and Invest.

Authors:  Anand Shah; Darius Armstrong-James; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-09-07       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.